GGrantIndex
← Leaderboards

Deborah J Donnell

Fred Hutchinson Cancer Center

$179,670,738
Attributed
$205,644,481
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $28.5M · FY200825
$50M$37.5M$25M$12.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$205,644,481 · 3

By mechanism

UM1$185,312,322 · 1
U01$18,932,159 · 1
R13$1,400,000 · 1

Top collaborators

Most similar at Fred Hutchinson Cancer Center

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignReportingClinical TrialsLeadershipData ManagementPreventionEpidemicAids PreventionHiv InfectionsProgramsMonitorHiv Prevention Trials NetworkFacultySpecimenLaboratoriesTransmission ProcessInnovationMathematical ModelStatistical MethodsSiteTrainingPreventRandomizedAids/Hiv Problem

Grant awards (25)

SDMC: HIV Prevention Trials Network$19,992,286
UM1 · FY2025 · AI · contact PI
HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy$8,473,830
UM1 · FY2025 · AI · contact PI
SDMC: HIV Prevention Trials Network$20,886,260
UM1 · FY2024 · AI · contact PI
SDMC: HPTN 084 Pregnancy Supplement$1,195,111
UM1 · FY2024 · AI · contact PI
SDMC: HIV Prevention Trials Network$14,385,924
UM1 · FY2023 · AI · contact PI
HIVR4P 2023, the 5th HIV Research for Prevention Conference, Lima, Peru, and virtually, 22-26 October 2023$1,400,000
R13 · FY2023 · AI
SDMC: HIV Prevention Trials Network$9,407,209
UM1 · FY2022 · AI · contact PI
SDMC: HIV Prevention Trials Network$4,802,446
UM1 · FY2022 · AI · contact PI
CoVPN 5002: SARS-CoV-2 Prevalence Study -Supplement Request$389,142
UM1 · FY2022 · AI · contact PI
SDMC: HIV Prevention Trials Network$17,784,015
UM1 · FY2021 · AI · contact PI
CoVPN 5002: SARS-CoV-2 Prevalence Study - Year 2$978,683
UM1 · FY2021 · AI · contact PI
SDMC: HIV Prevention Trials Network$11,531,902
UM1 · FY2020 · AI · contact PI
CoVPN 5002: SARS-CoV-2 Prevalence Study$295,993
UM1 · FY2020 · AI · contact PI
SDMC: HIV Prevention Trials Network$12,822,234
UM1 · FY2019 · AI · contact PI
SDMC: HIV Prevention Trials Network$11,597,790
UM1 · FY2018 · AI · contact PI
SDMC: HIV Prevention Trials Network$8,034,819
UM1 · FY2017 · AI · contact PI
SDMC: HIV Prevention Trials Network$9,822,842
UM1 · FY2016 · AI · contact PI
SDMC: HIV Prevention Trials Network$9,184,867
UM1 · FY2015 · AI · contact PI
SDMC: HIV Prevention Trials Network$9,426,158
UM1 · FY2014 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network$2,835,895
UM1 · FY2013 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network$5,673,078
UM1 · FY2012 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network$5,791,838
UM1 · FY2011 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network$4,752,947
U01 · FY2010 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network$7,311,592
U01 · FY2009 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network$6,867,620
U01 · FY2008 · AI · contact PI